These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 2383262)

  • 21. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).
    Miyamoto Y; Habata Y; Ohtaki T; Masuda Y; Ogi K; Onda H; Fujino M
    Biochim Biophys Acta; 1994 Aug; 1218(3):297-307. PubMed ID: 8049255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K; Smith DM; Ghatei MA; Murphy JK; Bloom SR
    J Clin Endocrinol Metab; 1991 May; 72(5):958-64. PubMed ID: 1673686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain.
    Suda K; Smith DM; Ghatei MA; Bloom SR
    Neurosci Lett; 1992 Mar; 137(1):19-23. PubMed ID: 1320752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
    Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
    Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands.
    Vigh S; Arimura A; Gottschall PE; Kitada C; Somogyvári-Vigh A; Childs GV
    Peptides; 1993; 14(1):59-65. PubMed ID: 8441707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide (PACAP/VIP) hybrids and related peptides by rat brain membranes.
    Ando E; Nokihara K; Naruse S; Wray V
    Biomed Pept Proteins Nucleic Acids; 1996; 2(2):41-6. PubMed ID: 9346825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prohormone convertases 1 and 2 process ProPACAP and generate matured, bioactive PACAP38 and PACAP27 in transfected rat pituitary GH4C1 cells.
    Li M; Shuto Y; Somogyvári-Vigh A; Arimura A
    Neuroendocrinology; 1999 Mar; 69(3):217-26. PubMed ID: 10087454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
    Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
    Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular identification of receptor for pituitary adenylate cyclase activating polypeptide.
    Ohtaki T; Watanabe T; Ishibashi Y; Kitada C; Tsuda M; Gottschall PE; Arimura A; Fujino M
    Biochem Biophys Res Commun; 1990 Sep; 171(2):838-44. PubMed ID: 2169736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-stimulated cyclic AMP synthesis in rat cerebral cortical slices: interaction with noradrenaline, adrenaline, and forskolin.
    Nowak JZ; Kuba K
    J Mol Neurosci; 2002; 18(1-2):47-52. PubMed ID: 11931349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on exocrine pancreatic secretion in dogs.
    Naruse S; Suzuki T; Ozaki T
    Pancreas; 1992; 7(5):543-7. PubMed ID: 1513802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships.
    Starr CG; Maderdrut JL; He J; Coy DH; Wimley WC
    Peptides; 2018 Jun; 104():35-40. PubMed ID: 29654809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.